66 related articles for article (PubMed ID: 18770865)
1. Why do large breast cancers still present in a population offered screening?
Kricker A; Newman B; Gertig DM; Goumas C; Armes J; Armstrong BK
Int J Cancer; 2008 Dec; 123(12):2907-14. PubMed ID: 18770865
[TBL] [Abstract][Full Text] [Related]
2. Bodyweight and other correlates of symptom-detected breast cancers in a population offered screening.
Kricker A; Disipio T; Stone J; Goumas C; Armes JE; Gertig DM; Armstrong BK
Cancer Causes Control; 2012 Jan; 23(1):89-102. PubMed ID: 22020871
[TBL] [Abstract][Full Text] [Related]
3. Population attributable risk of modifiable risk factors associated with invasive breast cancer in women aged 45-69 years in Queensland, Australia.
Wilson LF; Page AN; Dunn NA; Pandeya N; Protani MM; Taylor RJ
Maturitas; 2013 Dec; 76(4):370-6. PubMed ID: 24113278
[TBL] [Abstract][Full Text] [Related]
4. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
5. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: prognostic indicators of screen-detected cancers in New South Wales, Australia.
Randall D; Morrell S; Taylor R; Hung WT
Cancer Causes Control; 2009 Jul; 20(5):559-66. PubMed ID: 19015941
[TBL] [Abstract][Full Text] [Related]
6. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
7. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
8. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
9. Correlates of mammogram density in southwestern Native-American women.
Roubidoux MA; Kaur JS; Griffith KA; Sloan J; Wilson C; Novotny P; Lobell M
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):552-8. PubMed ID: 12815002
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk factors in Queensland women attending population-based mammography screening.
Protani M; Page A; Taylor R; Glazebrook R; Lahmann PH; Branch E; Muller J
Maturitas; 2012 Mar; 71(3):279-86. PubMed ID: 22225652
[TBL] [Abstract][Full Text] [Related]
11. Biennial versus annual mammography and the risk of late-stage breast cancer.
White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Glass AG; Lacey JV; Carreon JD; Hoover RN
J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
[TBL] [Abstract][Full Text] [Related]
13. Population-based mammography screening and breast cancer incidence in New South Wales, Australia.
Chiu C; Morrell S; Page A; Rickard M; Brassil A; Taylor R
Cancer Causes Control; 2006 Mar; 17(2):153-60. PubMed ID: 16425093
[TBL] [Abstract][Full Text] [Related]
14. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
15. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
20. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
